Nang Kuang Pharmaceutical , Ltd. Profit Margin

Nang Kuang Pharmaceutical , Ltd. (1752.TW) currently reports a profit margin of 9.66% as of June 2026. That compares with 11.78% in the prior-year period — down 18.0% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore Nang Kuang Pharmaceutical , Ltd.'s profit margin history and peer comparisons.

Nang Kuang Pharmaceutical , Ltd.'s profit margin decreased from 11.78% to 9.66% — a 18.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nang Kuang Pharmaceutical , Ltd.'s profit margin of 9.66% is lower than the its sector sector average of 13.23%. That is roughly 27.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Nang Kuang Pharmaceutical , Ltd.'s current 9.66% should be judged against industry norms (sector average: 13.23%) and against 1752.TW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 9.66%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Nang Kuang Pharmaceutical , Ltd., and consider following 1752.TW for alerts when major investors trade the stock.